Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.

MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Arthroplasty, published by BMC, is a prestigious open-access journal dedicated to disseminating cutting-edge research in the fields of orthopedics and sports medicine, as well as surgical advancements. Since its inception in 2019, this journal has rapidly established itself as a leading platform for scholars and clinicians alike, with a remarkable position in the 2023 category quartiles—ranking Q2 in Orthopedics and Sports Medicine and Q1 in Surgery. Based in the United Kingdom, at CAMPUS, 4 Crinan St, London, the journal promotes unrestricted access to valuable research findings, fostering a collaborative environment for professionals aiming to improve surgical outcomes and patient care. With its current Scopus ranks of #250 in Medicine (Surgery) and #180 in Medicine (Orthopedics and Sports Medicine), Arthroplasty is an essential resource for researchers, professionals, and students aiming to remain at the forefront of their fields. As the journal continues to evolve over the converged years from 2019 to 2024, it remains committed to enhancing the quality and accessibility of orthopedic research.

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Arthroplasty Today is a distinguished journal published by Elsevier that has been at the forefront of orthopedic research since its launch in 2015. With a commitment to open access, the journal provides a platform for disseminating high-quality research in both the Orthopedics and Sports Medicine fields and Surgery, holding respectable positions in Scopus rankings with an impressive Q1 and Q2 quartile status. The journal aims to foster collaboration and innovation among researchers, healthcare professionals, and students by publishing cutting-edge studies, clinical outcomes, and advancements in arthroplasty techniques. Operating out of the United States, Arthroplasty Today not only enhances visibility for its contributors but also enriches the global discourse on orthopedic procedures, catering to a diverse audience eager to stay informed of the latest findings and methodologies. Access to this wealth of information is unrestricted, ensuring that relevant knowledge is available to all stakeholders in the medical community.

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

Klimik Journal is a pivotal publication in the fields of Infectious Diseases and Medical Microbiology, serving as a platform for researchers, clinicians, and academics to disseminate groundbreaking findings and improve health outcomes. Established in 2010 and published by DOC DESIGN INFORMATICS CO LTD, this journal is dedicated to advancing knowledge and fostering discussions around critical issues in infectious diseases and microbial research. With an ISSN of 1301-143X and an E-ISSN of 1309-1484, Klimik Journal strives to maintain high academic standards despite currently ranking in the fourth quartile in both categories according to Scopus metrics, which highlights the need for continued contributions to the field. Operating from Turkey, the journal is committed to supporting open access options, thereby ensuring wide dissemination of research findings. As it continues to bridge the gap between theory and practice, Klimik Journal is poised to become an essential resource for those looking to stay at the forefront of infectious disease research and microbiological advancements.

Journal of Bone and Joint Infection, published by COPERNICUS GESELLSCHAFT MBH, is a pioneering open-access journal dedicated to the multidisciplinary field of bone and joint infections. Since its inception in 2016, it has served as a vital platform for researchers and practitioners to share cutting-edge findings, clinical practices, and innovative research methodologies from around the globe. Based in Germany, this journal has quickly established itself with a significant impact, currently holding a Q3 placement in Infectious Diseases and Q2 in both Orthopedics & Sports Medicine and Surgery, alongside commendable Scopus rankings. With the aim of advancing knowledge and fostering collaboration in the treatment and understanding of osteoarticular infections, the journal invites submissions that contribute to the scientific community's quest for effective management strategies and improved patient outcomes. The open-access format ensures that groundbreaking research is readily accessible, promoting wider dissemination and visibility within the community. As the Journal of Bone and Joint Infection continues through its converged years (2016-2024), it remains committed to supporting ongoing education and innovation in this critical area of medical research.

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.